The researchers’ focus has been on dense protein deposits that form in the skin cells before they become corneocytes — resembling droplets of vinegar in oil. This is phase separation in action, when liquids of mismatched properties come together.
These protein deposits are called keratohyalin granules, or KGs, and they resemble other membraneless organelles in cells, because they are not bound by lipid membranes. An absence of KGs is common in skin barrier disorders. Despite this strong association with human disease, the function of KGs was unknown.
Quiroz and his colleagues developed transgenic mice with a fluorescent phase separation sensor, which helped them identify the key role KGs play in skin. Their work demonstrated that intrinsically disordered proteins of the skin program the formation and properties of KGs through a vinegar-in-oil type of phase separation.
The main protein involved, filaggrin — or FLG — is often mutated in skin barrier disorders. Basically, when FLG is faulty and phase separation doesn’t happen, it opens the door to diseases of the skin barrier. The team’s research was first to establish a role for LLPS in a human tissue.
Based on the work reported in Science, Quiroz was invited by the Society for Investigative Dermatology to offer some perspective for JID Innovations. He enlisted Alexa Avecilla, a Ph.D. student in his lab, as lead author.
“Our goal in this review article is to discuss the current progress in this nascent area for skin research,” Avecilla said. “Specifically, how the discovery of liquid-liquid phase separation in skin-residing, membraneless organelles will influence understanding of the complex processes of skin barrier formation.”
The focus this time is broader than a research article; it’s more about perspective, Quiroz said, but it also works as a companion piece to the study published in Science. And it gives Quiroz and his team an opportunity to share their latest research directly with the people who ultimately will use it on the front lines of clinical care.
“We’re communicating here with the scientists and clinicians who are always thinking about diseases of the skin, the dermatologists and skin biologists,” Quiroz said. “And that will have an impact on the eventual translation of our LLPS-inspired ideas.”